ARCT insider transaction filings

Arcturus Therapeutics Holdings Inc. — 21 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen ARCT transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-154Markels John — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-154Marantz Jing L. — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-154Slaoui Moncef — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-154Marquet Magda — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-154HOLMES EDWARD W — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-154BARLOW JAMES F — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2026-06-154FARRELL PETER C — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2026-05-074MULROY DENNIS — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-12-194Roberts Joseph — ControllerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-12-194Kurata Lance — Chief Legal OfficerGrant/award (A): 54,000 (derivative) @ $0EDGAR
2025-12-194Chivukula Pad — Chief Scientific Officer & COOGrant/award (A): 54,000 (derivative) @ $0EDGAR
2025-12-194Payne Joseph E — President and CEO, DirectorGrant/award (A): 175,000 (derivative) @ $0EDGAR
2025-08-204/ASASSINE ANDY — Chief Financial Officer, DirectorPurchase (P): 1,238 @ $16.56EDGAR
2025-08-194SASSINE ANDY — Chief Financial Officer, DirectorPurchase (P): 1,238 @ $16.56EDGAR
2025-06-114Markels John — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-114Marantz Jing L. — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-114Slaoui Moncef — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-114Marquet Magda — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-114HOLMES EDWARD W — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-114BARLOW JAMES F — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-114FARRELL PETER C — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR

Recent 8-K events — Arcturus Therapeutics Holdings Inc.

FiledFormItems reportedSource
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-228-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-298-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ARCT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →